SCHEMBL16624326

SCHEMBL16624326

CCOc1ccc(Cc2c(C)nc(N)nc2O)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
TSHR P16473 3/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 3/20 0.39
DHFR P00374 3/20 0.38
TLR7 Q9NYK1 1/20 0.37
GAA P10253 1/20 0.37
MAPK10 P53779 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP1A2 P05177 1/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624324 0.91 SMN1; SMN2 (0.46) KMT2AATMSMN1; SMN2LMNATSHR
SCHEMBL16624328 0.90 NPSR1 (0.37) KMT2AATMTSHRMAPTDHFR
SCHEMBL16624354 0.87 TLR7 (0.41) KMT2ASMN1; SMN2KDM4EMAPTDHFR
SCHEMBL16624329 0.82 NPSR1 (0.40) KMT2AATMDHFRTLR7NPSR1
SCHEMBL16624352 0.81 DHFR (0.39) KMT2AMAPTDHFRTLR7ALDH1A1
SCHEMBL15305572 0.79 CYP1A2 (0.36) SMN1; SMN2DHFRTLR7ALDH1A1CYP1A2
SCHEMBL16624323 0.78 TLR7 (0.39) DHFRTLR7NPSR1
SCHEMBL16624314 0.77 TLR7 (0.41) ATMSMN1; SMN2KDM4EHPGDMAPT
SCHEMBL16624316 0.76 HSP90AB1 (0.40) DHFRTLR7
SCHEMBL16626811 0.75 TLR7 (0.51) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2016-09-01 US disclosed
US-9376398-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD (JP) 2016-06-28 US disclosed
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS Sumitomo Pharma Co., Ltd. (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 KMT2A 2031/4885ATM 2789/4885SMN1; SMN2 1872/4885
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 KMT2A 2031/4885ATM 2789/4885SMN1; SMN2 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.